Patents Assigned to Anwita Biosciences, Inc.
  • Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
    Patent number: 11897930
    Abstract: Provided herein are an interleukin-2 polypeptide and a fusion protein thereof. Also provided herein are their pharmaceutical compositions and methods of use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: February 13, 2024
    Assignee: Anwita Biosciences, Inc.
    Inventors: Fan Ye, Eric Liao, Ella Li, Matthew Siegel, Jianing Huang, Ziyang Zhong
  • CYTOKINE FUSION PROTEINS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
    Publication number: 20230348549
    Abstract: Provided herein are a fusion protein comprising first and second cytokine domains, and a half-life extension domain; and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Application
    Filed: July 2, 2023
    Publication date: November 2, 2023
    Applicant: Anwita Biosciences, Inc.
    Inventors: Ziyang Zhong, Fan Ye, Matthew Siegel, Jianing Huang
  • Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications
    Patent number: 11692020
    Abstract: Provided herein are a fusion protein comprising first and second cytokine domains, and a half-life extension domain; and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: July 4, 2023
    Assignee: Anwita Biosciences, Inc.
    Inventors: Ziyang Zhong, Fan Ye, Matthew Siegel, Jianing Huang
  • INTERLEUKIN-22 FUSION PROTEINS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
    Publication number: 20220033454
    Abstract: Provided herein are a fusion protein comprising an interleukin-22 domain and an albumin binding domain, and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an inflammatory disease.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Applicant: Anwita Biosciences, Inc.
    Inventors: Ziyang Zhong, Fan Ye, Jianing Huang, Matthew Siegel, Ji Wang
  • CYTOKINE FUSION PROTEINS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
    Publication number: 20210163565
    Abstract: Provided herein are a fusion protein comprising first and second cytokine domains, and a half-life extension domain; and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Application
    Filed: November 19, 2020
    Publication date: June 3, 2021
    Applicant: Anwita Biosciences, Inc.
    Inventors: Ziyang Zhong, Fan Ye, Matthew Siegel, Jianing Huang